Newstral
Article
Seattle Times on 2021-02-11 08:45
AstraZeneca says 4th-Q earns triple on cancer drugs sales
Related news
- BEU drugs regulator approves AstraZeneca vaccinebbc.co.uk
- Elana Meyers Taylor earns 4th monobob win this seasonSeattle Times
- QB earns Tide's 4th Heismannwaonline.com
- Osaka earns 4th Grand Slam titlenwaonline.com
- LTriple Negative Breast Cancer Market Companies, Drugs, Market Drivers, Market Barriers, and Market Report Scope 2032liverpoolstudentmedia.com
- AstraZeneca PLC: Cancer drugs help AstraZeneca beat forecastsFinancial Times
- AstraZeneca revenue down as key drugs lose patent protectionseattletimes.com
- AstraZeneca earnings up 55% driven by sales of cancer drugsSeattle Times
- FAstraZeneca to pay $600m for Actavis drugsft.com
- AstraZeneca boosted by strong drugs s...Shropshire Star
- $230M deal: AstraZeneca forms COPD drugs collaborationbizjournals.com
- Seidel earns marathon bronze, predicted medal in 4th gradeSeattle Times
- Suspects in Little Rock triple slaying charged in 4th deathSeattle Times
- AstraZeneca, German firm to try speeding vaccine deliverySeattle Times
- AstraZeneca expects updated COVID-19 vaccine by autumndailyherald.com
- LEndocrinology Drugs Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: AbbVie, Merck, AstraZeneca, Eli Lilly, Sanofi, Novo Nordisk…liverpoolstudentmedia.com
- Freund earns 4th straight ski jump World Cup winartesianews.com